Glycotest, Inc.
PrivateLast Round
Seed Round
Jul 16, 2026
Est. Valuation
$25M
Total Funding Raised
$13.81M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Glycotest, Inc. is a diagnostics company that specializes in the commercialization of non-invasive blood tests for the early detection of liver cancers and fibrosis-cirrhosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Glycotest, Inc. Comparables
Compare Glycotest, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Helio Genomics | 90% | |
| Mursla Bio | 81% | |
| Hepta Bio | 79% |
Glycotest, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Jul 16, 2026 | ||||
| VC Round | Jan 23, 2024 | ||||
| Convertible Debt | May 2, 2023 | ||||
| Series A Extension | Nov 21, 2019 | ||||
| Series A | Oct 22, 2018 |
Key People
Founding team and executive leadership
Glycotest, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EMV Capital | Series A Extension, VC Round, Series A, Seed Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2026
$3.2M round led by EMV Capital
- May 18, 2026
Monthly visitors increased 118% MoM.
Glycotest, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Glycotest, Inc.'s valuation, stock price, and market status.
Is Glycotest, Inc. a public or private company?
Glycotest, Inc. is a private company.
What is the current stock price of Glycotest, Inc.?
Glycotest, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Glycotest, Inc. worth (valuation)?
Glycotest, Inc.'s valuation is estimated at $25.0M based on funding round data.
Can I buy Glycotest, Inc. stock?
Glycotest, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Glycotest, Inc.'s last funding round?
Glycotest, Inc.'s most recent funding round was Series A Extension on November 21, 2019.
Who are the main investors in Glycotest, Inc.?
Key investors in Glycotest, Inc. include EMV Capital.
Will Glycotest, Inc. IPO soon?
No public IPO plans have been announced for Glycotest, Inc..
How can I track Glycotest, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Glycotest, Inc.'s secondary market activity and sign up for updates.